iShares U.S. Pharmaceuticals ETF closed at $103.19 on Sep 28, up 0.64%, 4.6% below its 52-week closing high. Volume of 69.7K shares was 0.44× its 20-day average (below normal).
Split-adjusted performance: -1.5% over one month, +23.2% over six months, +49.4% over one year.
Short interest was 334.0K shares at the Sep 15 settlement, down 20.0% from the prior report (2.0 days to cover).
Does iShares U.S. Pharmaceuticals ETF pay a dividend?
Yes. The latest regular dividend was $0.2789 per share (ex-date Sep 15), an annualised yield of 1.08%.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology